The relationship between fluticasone furoate systemic exposure and cortisol suppression.
Allen A.
Clin Pharmacokinet · meta-analysis; research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s40262-013-0078-1 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för fluticasone furoate. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
23 träffarEfficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial.
Woodcock A, Bleecker ER, Lötvall J, O'Byrne PM, Bateman ED, Medley H, Ellsworth A, Jacques L, Busse WW.
Chest · comparative study; research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1378/chest.13-0178The safety, pharmacokinetics and pharmacodynamics of a combination of fluticasone furoate and vilanterol in healthy Japanese subjects.
Nakahara N, Wakamatsu A, Kempsford R, Allen A, Yamada M, Nohda S, Hirama T.
Int J Clin Pharmacol Ther · research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.5414/cp201822Systemic safety of fluticasone furoate/vilanterol combination.
Lipworth B.
Thorax · letter; comment · DOI 10.1136/thoraxjnl-2013-203910Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.
Allen A, Schenkenberger I, Trivedi R, Cole J, Hicks W, Gul N, Jacques L.
Clin Respir J · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/crj.12026The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.
Kempsford R, Allen A, Bal J, Rubin D, Tombs L.
Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/bcp.12019Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study.
LaForce C, Journeay GE, Miller SD, Silvey MJ, Wu W, Lee LA, Chylack LT.
Ann Allergy Asthma Immunol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.anai.2013.04.013An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis.
Wu W, Walters RD, Nadeau GA, Botnick W, Broughton N.
Allergy Asthma Proc · meta-analysis; research support, non-u.s. gov't; journal article · DOI 10.2500/aap.2013.34.3662Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial.
Busse WW, O'Byrne PM, Bleecker ER, Lötvall J, Woodcock A, Andersen L, Hicks W, Crawford J, Jacques L, Apoux L, Bateman ED.
Thorax · clinical trial, phase iii; comparative study; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1136/thoraxjnl-2012-202606A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD.
Kerwin EM, Scott-Wilson C, Sanford L, Rennard S, Agusti A, Barnes N, Crim C.
Respir Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2012.12.014Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.
Martinez FJ, Boscia J, Feldman G, Scott-Wilson C, Kilbride S, Fabbri L, Crim C, Calverley PM.
Respir Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2012.12.016Adrenal suppression with fluticasone furoate.
Lipworth BJ.
Ann Allergy Asthma Immunol · letter; comment · DOI 10.1016/j.anai.2012.12.009Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
Allen A, Bareille PJ, Rousell VM.
Clin Pharmacokinet · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1007/s40262-012-0021-xEffect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
Baroody FM, Logothetis H, Vishwanath S, Bashir M, Detineo M, Naclerio RM.
Am J Rhinol Allergy · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.2500/ajra.2013.27.3841Influence of renal and hepatic impairment on the pharmacokinetic and pharmacodynamic properties and tolerability of fluticasone furoate and vilanterol in combination.
Allen A, Davis A, Hardes K, Tombs L, Kempsford R.
Clin Ther · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2012.11.001The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol.
Vestbo J, Anderson J, Brook RD, Calverley PM, Celli BR, Crim C, Haumann B, Martinez FJ, Yates J, Newby DE.
Eur Respir J · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1183/09031936.00087312Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study.
Keith PK, Dymek A, Pfaar O, Fokkens W, Yun Kirby S, Wu W, Garris C, Topors N, Lee LA.
Prim Care Respir J · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.4104/pcrj.2012.00039Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial.
Oliver A, Quinn D, Goldfrad C, van Hecke B, Ayer J, Boyce M.
Clin Transl Allergy · research-article; journal article · DOI 10.1186/2045-7022-2-11Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
Bateman ED, Bleecker ER, Lötvall J, Woodcock A, Forth R, Medley H, Davis AM, Jacques L, Haumann B, Busse WW.
Respir Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2012.01.004Fluticasone furoate: a new intranasal corticosteroid.
Kumar R, Kumar D, Parakh A.
J Postgrad Med · review; journal article · DOI 10.4103/0022-3859.93260No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.
Fokkens WJ, Rinia B, van Drunen CM, Hellings PW, Hens G, Jansen A, Blom H, Wu W, Clements DS, Lee LA, Philpot EE.
Am J Rhinol Allergy · multicenter study; randomized controlled trial; journal article · DOI 10.2500/ajra.2012.26.3675Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children.
Kersten ET, van Leeuwen JC, Brand PL, Duiverman EJ, de Jongh FH, Thio BJ, Driessen JM.
Pediatr Pulmonol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1002/ppul.21511Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
Busse WW, Bleecker ER, Bateman ED, Lötvall J, Forth R, Davis AM, Jacques L, Haumann B, Woodcock A.
Thorax · clinical trial, phase ii; comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1136/thoraxjnl-2011-200308